153 related articles for article (PubMed ID: 27009842)
1. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
[TBL] [Abstract][Full Text] [Related]
2. Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.
Brady SW; Liu Y; Ma X; Gout AM; Hagiwara K; Zhou X; Wang J; Macias M; Chen X; Easton J; Mulder HL; Rusch M; Wang L; Nakitandwe J; Lei S; Davis EM; Naranjo A; Cheng C; Maris JM; Downing JR; Cheung NV; Hogarty MD; Dyer MA; Zhang J
Nat Commun; 2020 Oct; 11(1):5183. PubMed ID: 33056981
[TBL] [Abstract][Full Text] [Related]
3. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
[TBL] [Abstract][Full Text] [Related]
4. Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
Schmelz K; Toedling J; Huska M; Cwikla MC; Kruetzfeldt LM; Proba J; Ambros PF; Ambros IM; Boral S; Lodrini M; Chen CY; Burkert M; Guergen D; Szymansky A; Astrahantseff K; Kuenkele A; Haase K; Fischer M; Deubzer HE; Hertwig F; Hundsdoerfer P; Henssen AG; Schwarz RF; Schulte JH; Eggert A
Nat Commun; 2021 Nov; 12(1):6804. PubMed ID: 34815394
[TBL] [Abstract][Full Text] [Related]
5. Frequency and signature of somatic variants in 1461 human brain exomes.
Wei W; Keogh MJ; Aryaman J; Golder Z; Kullar PJ; Wilson I; Talbot K; Turner MR; McKenzie CA; Troakes C; Attems J; Smith C; Sarraj SA; Morris CM; Ansorge O; Jones NS; Ironside JW; Chinnery PF
Genet Med; 2019 Apr; 21(4):904-912. PubMed ID: 30214067
[TBL] [Abstract][Full Text] [Related]
6. Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing.
Huskova H; Ardin M; Weninger A; Vargova K; Barrin S; Villar S; Olivier M; Stopka T; Herceg Z; Hollstein M; Zavadil J; Korenjak M
Oncogene; 2017 Oct; 36(43):6041-6048. PubMed ID: 28692054
[TBL] [Abstract][Full Text] [Related]
7. Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.
Corallo D; Zanon C; Pantile M; Tonini GP; Zin A; Francescato S; Rossi B; Trevisson E; Pinato C; Monferrer E; Noguera R; Aliño SF; Herrero MJ; Biffi A; Viscardi E; Aveic S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685674
[TBL] [Abstract][Full Text] [Related]
8. Somatic Variants and Exon-Level Copy Number Changes in Five Hyperplastic Oral Leukoplakias.
Anne A; Kumar L; Salavadi RK; Anand PS; Nuguri S; Bindra S; Reddy KVR; Gummanur MR; Mohan KN
Cytogenet Genome Res; 2022; 162(10):560-569. PubMed ID: 36630923
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing of hepatocellular carcinoma in lemurs identifies potential cancer drivers: A pilot study.
Gunady EF; Ware KE; Hoskinson Plumlee S; Devos N; Corcoran D; Prinz J; Misetic H; Ciccarelli FD; Harrison TM; Thorne JL; Schopler R; Everitt JI; Eward WC; Somarelli JA
Evol Med Public Health; 2022; 10(1):221-230. PubMed ID: 35557512
[TBL] [Abstract][Full Text] [Related]
10. Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes.
Hussein D; Dallol A; Quintas R; Schulten HJ; Alomari M; Baeesa S; Bangash M; Alghamdi F; Khan I; ElAssouli MM; Saka M; Carracedo A; Chaudhary A; Abuzenadah A
Heliyon; 2020 Nov; 6(11):e05632. PubMed ID: 33305042
[TBL] [Abstract][Full Text] [Related]
11. Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis.
Boccarelli A; Del Buono N; Esposito F
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673990
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of whole genome and transcriptome sequencing in a young patient with gastric cancer provides insights for precision therapy.
Hu K; Yu W; Ajayi OE; Li L; Huang Z; Rong Q; Wang S; Wu QF
Oncol Lett; 2020 Oct; 20(4):115. PubMed ID: 32863928
[TBL] [Abstract][Full Text] [Related]
13. Germline POT1 mutation and neuroblastoma: A mere coincidence or true association.
Legrand C; Peysselon M; Bidart M; Bouras A
Pediatr Blood Cancer; 2024 May; ():e31054. PubMed ID: 38706191
[No Abstract] [Full Text] [Related]
14. An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.
Formicola D; Petrosino G; Lasorsa VA; Pignataro P; Cimmino F; Vetrella S; Longo L; Tonini GP; Oberthuer A; Iolascon A; Fischer M; Capasso M
J Transl Med; 2016 May; 14(1):142. PubMed ID: 27188717
[TBL] [Abstract][Full Text] [Related]
15. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
Evageliou NF; Haber M; Vu A; Laetsch TW; Murray J; Gamble LD; Cheng NC; Liu K; Reese M; Corrigan KA; Ziegler DS; Webber H; Hayes CS; Pawel B; Marshall GM; Zhao H; Gilmour SK; Norris MD; Hogarty MD
Clin Cancer Res; 2016 Sep; 22(17):4391-404. PubMed ID: 27012811
[TBL] [Abstract][Full Text] [Related]
16. TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.
Amin AD; Li L; Rajan SS; Gokhale V; Groysman MJ; Pongtornpipat P; Tapia EO; Wang M; Schatz JH
Oncotarget; 2016 Apr; 7(17):23715-29. PubMed ID: 27009859
[TBL] [Abstract][Full Text] [Related]
17. Genetics of Bladder Malignant Tumors in Childhood.
Zangari A; Zaini J; Gulìa C
Curr Genomics; 2016 Feb; 17(1):14-32. PubMed ID: 27013922
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.
Woodfield SE; Guo RJ; Liu Y; Major AM; Hollingsworth EF; Indiviglio S; Whittle SB; Mo Q; Bean AJ; Ittmann M; Lopez-Terrada D; Zage PE
Genes Cancer; 2016 Jan; 7(1-2):13-26. PubMed ID: 27014418
[TBL] [Abstract][Full Text] [Related]
19. A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.
Dvorkina M; Nieddu V; Chakelam S; Pezzolo A; Cantilena S; Leite AP; Chayka O; Regad T; Pistorio A; Sementa AR; Virasami A; Barton J; Montano X; Lechertier T; Brindle N; Morgenstern D; Lebras M; Burns AJ; Saunders NJ; Hodivala-Dilke K; Bagella L; De The H; Anderson J; Sebire N; Pistoia V; Sala A; Salomoni P
Clin Cancer Res; 2016 Jul; 22(13):3398-409. PubMed ID: 27076624
[TBL] [Abstract][Full Text] [Related]
20. ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment.
Valle-García D; Qadeer ZA; McHugh DS; Ghiraldini FG; Chowdhury AH; Hasson D; Dyer MA; Recillas-Targa F; Bernstein E
Epigenetics; 2016 Jun; 11(6):398-414. PubMed ID: 27029610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
